Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,...
Patent
1995-06-07
1999-10-12
Caputa, Anthony C.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
A61K 39395
Patent
active
059651300
ABSTRACT:
This invention provides therapeutic methods for inhibiting tumor metastasis and for treating primary tumors. The methods of this invention do not cause serious side effects and will be effective for a broad spectrum of cancerous diseases. In particular, the invention discloses a novel method comprising administering to a mammal a preparation of intravenous immunoglobulin (IVIG). The IVIG preparation to be administered according to this invention may contain intact immunoglobulin molecules or fragments of immunoglobulins. The preparation is administered parenterally, preferably via intravenous, intracavitary or subcutaneous routes, either as a sole agent or in combination with other agents or methods which are commonly used for cancer treatment.
REFERENCES:
patent: 4699784 (1987-10-01), Terman et al.
Apffel, Charles A. et al., "Rejection of Lethal Ascites Tumors After Subcutaneous Inoculation: A Phenomenon of Antigenic Expression?", J. Nat. Cancer Inst., 39, pp. 1129-1139 (1967).
Attard, A.R. et. al., "The Use of Intravenous Immunoglobulin in Malignant Disorders", In Clinical Applications of Intravenous Immunoglobulin Therapy, P.L. Yap, ed., Churchill-Livingstone, pp. 203-229 (1992).
Beretta, G. et al., "Chemotherapty Versus Immunotherapy in the Treatment of Human Solidy Tumors", In Oncogenes to Tumor Antigens, G. Giraldo et al., eds., Elsevier (1985).
Besa, Emmauel C., "Recent Advances in the Treatment of Chronic Lymphocytic Leukemia: Defining the Role of Intravenous Immunoglobulin", Seminars in Hematology, 29, pp. 14-23 (1992).
Brunkhorst, U. et al., "Efficacy of Intravenous Immunoglobulins in Patients with Primary Immunodeficiency Diseases: Inadequacy of Current Dosage Practices and Approaches to the Problem", Journal of Clinical Immunology, 2, pp. 15S-21S (1982).
Buckley, Rebecca H., "Long Term Use of Intravenous Immune Globulin in Patients with Primary Immunodeficiency Diseases: Inadequacy of Current Dosage Practices and Approaches to the Problem", Journal of Clinical Immunology, 2, pp. 15S-21S (1982).
Buckley, Rebecca H. et al., "The Use of Intravenous Immune Globulin In Immunodeficiency Diseases", New England Journal of Medicine, 325, pp. 110-117 (1991).
Cafiero, F. et al., "Prophylaxis of Infection with Intravenous Immunoglobins plus Antibiotic for Patients at Risk for Sepsis Undergoing Surgeryh for Colorectal Cancer: Results of a Randomized, Multicenter Clinical Trial", Surgery, 112, pp. 24-31 (1992).
Coon, W.W. et al., "Experiences with Large Infusions of Gamma Globulin", American Journal of Surgery, 102, pp. 548-553 (1961).
Dwyer, John M., "Manipulating The Immune System With Immune Globulin", New England Journal of Medicine, 326, pp. 107-116 (1992).
Eibl, Martha M. et al., "Intravenous Immunoglobulin: A Review", Immunodeficiency Reviews, 1, pp. 1-42 (1989).
Forsberg, John-Gunnar et al., "Growth and Hormonal Responsiveness of Human Endometrial Carcinoma After Heterologous Transplantation to Neonatal Rats", Journal of the National Cancer Institute, 43, pp. 191-201 (1969).
Hague, R.A. et al., "Intravenous Immunoglobuln in HIV Infection: Evidence for the Efficacy of Treatment", Archives of Disease in Childhood, 64, pp. 1146-1150 (1989).
Hassig, A. "Lucky Strikes and mishaps in the Development and Clinical Use of Human Immunoglobulins", in Immunomodulation by Intravenous Immunoglobulin, Rewald E. And A. Morell (eds.), pp. 15-22 (1993).
Glynn, J.P. et al., "An Immunochemotherapeutic system for the Treatment of a Transplanted Moloney Virus-induced Lymphoma in Mice," Cancer Research, 29, pp. 515-550 (1969).
Moore, George E. et al., "Experimental and Clinical Adventures with Large Doses of Gamma and Other Globulins as Anticancer Agents", Surgery, 41, pp. 972-983 (1957).
Morell, A. et al., Prophylactic and Therapeutic use of Immunoglobulin for Intravenous Admission in Patients with Secondary Immunodeficiencies Associated with Malignancies, Pediat. Infect. Dis. J., 7, pp. S87-S91 (1988).
Mueller, B.M. and R.A. Reisfeld, "Potential of the SCID Mouse as a Host for Human Tumors", Cancer and Metastasis Reviews, 10, 193-200 (1991).
Needleman, Samuel W., "Durable Remission of Pure Red Cell Aplasia After Treatment With High-Dose Intravenous Gammaglobulin and Prednisone", American Journal of Hematology, 32, pp. 150-152 (1989).
Phillip, M.J. et al., "Effects of Coupled Tumor Specific Antigens (CTSA) on the Growth of Transplanted Tumors in C.sub.3 H/HEJ Mice", Oncology, 33 pp. 7-11 (1976).
Schlom, J., "Monoclonal Antibodies: They're More and Less Than You Think", In Molecular Foundations of Oncology, S. Broder, ed., Williams & Wilkins (1991).
Seidman, Andrew D. et al., "Immune-Mediated Thrombocytopenia Secondary to Suramin", Cancer, 71, pp. 851-854 (1993).
Shastri, Kaushik A. et al., "Acquired Factor VIII Inhibitor With Squamous Cell Cancer of the Epiglottis", Archives of Otolaryngology--Head & Neck Surgery, 116, pp. 350-353 (1990).
Stiehm, E. Richard et al., "Intravenous Immunoglobulins as Therapeutic Agents", Annals of Internal Medicine, 107, pp. 367-382 (1987).
Weeks, Jane C., "Cost Effectiveness of Prophylactic Intravenous Immune Globulin in Chronic Lymphocytic Leukemia", New England Journal of Medicine, 325, pp. 81-86 (1991).
Wein, John et al., "Influence of Antisera from Histoincompatible Mice on Electrophoretic Mobility of EL4 Tumor Cells", Cancer Research, 27, pp. 1066-1072 (1967).
Xie, X et al., "Comparative Studies Between Nude and SCID Mice on the Growth and Metastatic Behavior of Xenografted Human Tumors", Clin. Exp. Metastasis, 10, 201-210 (1992).
The National Institute of Child Health and Human Development Intravenous Immunoglobulin Study Group, "Intravenous Immune Globulin for the Prevention of Bacterial Infections in Children with Symptomatic Human Immunodeficiency Virus Infection", New England Journal of Medicine, 325, pp. 73-80 (1991).
NIH Consensus Conference, "Intravenous Immunoglobulin: Prevention and Treatment of Disease", JAMA, 264, pp. 3189-3193 (1990).
Fishman Pnina
Shoenfeld Yehuda
ARP Biomed Ltd.
Caputa Anthony C.
Massaro Jane A.
Navarro Mark
LandOfFree
Immunotherapeutic method of treating cancerous diseases by admin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunotherapeutic method of treating cancerous diseases by admin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunotherapeutic method of treating cancerous diseases by admin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-649403